A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/28/2001	CN1323579A Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same
11/28/2001	CN1323544A Compositions and method for lowering low density lipoprotein cholesterol concn.
11/28/2001	CN1075517C Method for extracting solomonscal polyose from Chinese herb medicine solomonseal rhizome
11/28/2001	CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/28/2001	CN1075500C Process of prepn. novel coumaric quinolone carboxylic acid and uses thereof
11/28/2001	CN1075499C Quninolone-acid naphthyridone carboxylic acid derivatives
11/28/2001	CN1075498C Charleston C-glucoside and its uses
11/28/2001	CN1075387C Antitumor agent potentiator comprising IL-6 antagonist
11/28/2001	CN1075378C Traditional Chinese medicine emulsion for anti cancer and prepn. method thereof
11/28/2001	CN1075377C Composite mannosans peptides oral liquor
11/28/2001	CN1075376C Nose drops
11/28/2001	CN1075375C Compounds with progesterone-antagonistic and anti-oestrogen properties intended from combined use in female contraception
11/28/2001	CN1075374C Heme antianemia medicine and preparation method
11/28/2001	CN1075373C Smoking inhibitor and using method therefor
11/28/2001	CN1075372C Indomethacin adhesive plaster
11/27/2001	US6323369 As analgesics
11/27/2001	US6323242 Treatment of disorders secondary to organic impairments
11/27/2001	US6323241 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/27/2001	US6323240 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
11/27/2001	US6323239 Treatment of addiction to ethanol and addictive-related behavior
11/27/2001	US6323238 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
11/27/2001	US6323237 Therapeutic compositions
11/27/2001	US6323236 Use of sulfamate derivatives for treating impulse control disorders
11/27/2001	US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001	US6323233 Diindole compounds as antiinflammatory agents
11/27/2001	US6323232 Combination therapy for osteoporosis
11/27/2001	US6323231 Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
11/27/2001	US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323226 Preventing congestive heart failure with cyclooxygenase enzyme
11/27/2001	US6323225 Pharmaceutical composition
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds
11/27/2001	US6323220 Substituted pyridine or piperidine compounds
11/27/2001	US6323218 Treatment of alzheimer*s disease with metal chelates for amyloidosis
11/27/2001	US6323217 Cardiovascular disorders
11/27/2001	US6323216 Selective antagonists of the 5-ht.sub.3 serotonin-like receptor and can therefore be used, as anti-emetics as well as in various pathological conditions of the central nervous system, and as antitussives.
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323213 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323211 Alpha.-adrenergic receptor antagonist and at least one compound that elevates endogenous nitric oxide or endothelium-derived relaxing factor in vivo
11/27/2001	US6323210 Transferase inhibitor
11/27/2001	US6323209 Method of treating or inhibiting colonic polyps
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323205 Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	US6323203 Antidiabetic agents for non-insulin dependent diabetes
11/27/2001	US6323202 Benzamide substitutes with ketone compounds as enzyme inhibitors
11/27/2001	US6323201 Compounds for inhibition of ceramide-mediated signal transduction
11/27/2001	US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response.
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323198 Cognition activators for gamma-aminobutyric acid binding receptors
11/27/2001	US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system
11/27/2001	US6323196 Galanthamine derivatives as acetylcholinesterase inhibitors
11/27/2001	US6323195 Enzyme inhibitors and cognition activators
11/27/2001	US6323194 Muscarinic agonists and antagonists
11/27/2001	US6323192 Chromium polynicotinate compositions and uses thereof for absorption of essential metals
11/27/2001	US6323191 Generation of chloride secretion from epithelial cells
11/27/2001	US6323190 Reproductive tract tissues and cardiovascular disorders
11/27/2001	US6323189 Stable liquid composition consisting essentially of chitosan, non-fatty acid or salt thereof, and water or aqueous solution
11/27/2001	US6323187 Therapeutic dinucleotide and derivatives
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6323183 Composition for and method of treatment using triterpenoids
11/27/2001	US6323182 Concentrate for use in preparation of dialysis solution comprising gluconic acid and glucose in amounts such that upon dilution with aqueous solution in ratio of at least about 1:150, specified concentrations are obtained
11/27/2001	US6323181 Antitumor agents
11/27/2001	US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001	US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/27/2001	US6323012 Method for treating viral infections
11/27/2001	US6323003 Compositions and methods for activating genes of interest
11/27/2001	US6322987 Carbamate-derivatized nucleosides and oligonucleosides
11/27/2001	US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001	US6322825 Compositions containing thymol and carvacrol and methods of treating gastrointestinal infections with the compositions
11/27/2001	US6322824 Use of hyperforin and hyperforin-containing extracts in the treatment of dementia diseases
11/27/2001	US6322819 Amphetamine salt covered with enteric release coating
11/27/2001	US6322817 Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
11/27/2001	US6322816 Fast-acting analgesic
11/27/2001	US6322812 Granulation of mesna with water, compression or compaction
11/27/2001	US6322805 Amphiphilic block polymer having units of polyethers and polylactones
11/27/2001	US6322802 Contacting with unconjugated dendritic polycation and an acid
11/27/2001	US6322798 Container closed with a cap containing ascorbic acid and perforable and/or detachable separator; toning, stimulation, regeneration, moisturizing effects, smoothness, softness attenuation of wrinkles, firmness, clarity of skin
11/27/2001	US6322797 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same
11/27/2001	US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression
11/27/2001	US6322550 Method for transdermal administration of GP IIb/IIIa antagonist
11/27/2001	US6322493 Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
11/27/2001	US6321750 Genital lubricant comprising a zinc salt which, when dissolved in water releases zinc ions at a concentration effective to reduce infectivity of a sexually transmitted virus and a package containing a condom and the lubricant
11/27/2001	CA2217573C Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
11/27/2001	CA2214037C Method of making camptothecin and camptothecin analogs
11/27/2001	CA2190396C Cosmetic compositions for artificial tanning
11/27/2001	CA2184551C Iron dextran formulations
11/27/2001	CA2179712C Crosslinked polymeric ammonium salts
11/27/2001	CA2079685C Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
11/27/2001	CA2045864C Stable salts of 4"-deoxy-4" epi-methylamino avermectin bla/blb
11/27/2001	CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/27/2001	CA2024863C The manufacture of pellets of xanthine derivatives
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/23/2001	CA2348301A1 Use of alpha-keto enamine derivatives as ingredients
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088159A2 Cd28 synthebody for the modulation of immune responses
11/22/2001	WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor

1 ... 5959 5960 5961 5962 5963 5964 5965 5966 5967 5968 5969 5970 5971 5972 5973 5974 5975 5976 5977 5978 5979 ... 7860